Institutions / ADAR1 Capital Management, LLC / Holdings
Back to ADAR1 Capital Management, LLC

ADAR1 Capital Management, LLC

All holdings · as of Dec 31, 2025

249 positions

CompanyClassValue ↓Shares% of portfolio
ABIVAX SA—$177.65M1,317,32913.3%
PROTAGONIST THERAPEUTICS INC—$91.63M1,049,1686.9%
Roivant Sciences Ltd.—$74.41M3,428,9625.6%
Immunovant, Inc.IMVTCommon Stock$63.07M2,480,9684.7%
Avidity Biosciences, Inc.—$39.42M546,5342.9%
EA SERIES TRUST—$38.80M337,1252.9%
SPDR S&P 500 ETF TR—$37.29M54,6842.8%
Cytokinetics Inc—$34.32M540,1662.6%
Septerna, Inc.SEPNCommon Stock$32.27M1,157,6112.4%
Arbutus Biopharma CorpABUSCommon Stock$26.05M5,415,1091.9%
Zai Lab Limited—$21.99M1,246,5201.6%
Terns Pharmaceuticals, Inc.—$21.88M541,6151.6%
CytomX Therapeutics, Inc.—$17.82M4,182,7691.3%
Celldex Therapeutics, Inc.—$17.57M646,7671.3%
RAPT THERAPEUTICS INC—$17.26M509,6791.3%
Inhibikase Therapeutics, Inc.—$16.53M8,063,9491.2%
BridgeBio Pharma, Inc.—$16.32M213,4141.2%
Monopar Therapeutics Inc.MNPRCommon Stock$15.27M233,9081.1%
VAXCYTE, INC.—$14.56M315,6421.1%
Crinetics Pharmaceuticals, Inc.—$14.40M309,3681.1%
Fulcrum Therapeutics, Inc.—$14.18M1,253,7491.1%
PROTHENA CORP PUBLIC LTD CO—$13.92M1,457,7641.0%
Lexeo Therapeutics, Inc.—$13.83M1,393,1611.0%
Taysha Gene Therapies, Inc.TSHACommon Stock$13.73M2,495,8091.0%
CIDARA THERAPEUTICS INC—$13.18M59,6771.0%
INVENTIVA SA—$12.60M2,709,8460.9%
ESTABLISHMENT LABS HOLDINGS INC.—$12.49M171,4220.9%
SPDR SERIES TRUST—$12.39M135,5850.9%
Replimune Group, Inc.—$12.07M1,241,3220.9%
IONIS PHARMACEUTICALS INC—$11.64M147,1300.9%
Revolution Medicines, Inc.—$11.56M145,0790.9%
Amylyx Pharmaceuticals, Inc.—$10.76M890,3560.8%
CG Oncology, Inc.—$10.72M258,1390.8%
TELEFLEX INC—$9.84M80,6270.7%
Invivyd, Inc.—$9.63M3,899,3970.7%
REGENERON PHARMACEUTICALS, INC.—$9.30M12,0510.7%
Xenon Pharmaceuticals Inc.—$9.14M203,9690.7%
Equillium, Inc.—$8.69M5,608,0780.7%
Savara IncSVRACommon Stock$8.47M1,405,4520.6%
Maze Therapeutics, Inc.—$7.44M179,5320.6%
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVAADR$7.36M235,9710.6%
CRESCENT BIOPHARMA, INC.—$7.19M606,0000.5%
Ovid Therapeutics Inc.—$6.98M4,285,0000.5%
BELITE BIO, INCBLTEADR$6.37M39,8390.5%
VERTEX PHARMACEUTICALS INC / MA—$6.22M13,7160.5%
Brighthouse Financial, Inc.—$6.19M95,5230.5%
Anteris Technologies Global Corp.—$6.18M1,238,7770.5%
AA MISSION ACQUISITION CORP—$6.17M578,3590.5%
Protara Therapeutics, Inc.—$6.06M1,136,7990.5%
Perceptive Capital Solutions Corp—$5.95M456,7200.4%
← PrevPage 1 of 5Next →